midazolam liconsa 2,5 mg
laboratorios liconsa s.a. - spania - midazolamum - solutie bucofaringiana - 2,5 mg/0.5ml - hipnotice si sedative benzodiazepine si derivati
midazolam liconsa 5 mg
laboratorios liconsa s.a. - spania - midazolamum - solutie bucofaringiana - 5 mg/1ml - hipnotice si sedative benzodiazepine si derivati
midazolam liconsa 7,5 mg
laboratorios liconsa s.a. - spania - midazolamum - solutie bucofaringiana - 72,5 mg/1.5ml - hipnotice si sedative benzodiazepine si derivati
okedi
laboratorios farmacéuticos rovi, s.a. - risperidone - schizofrenie - psiholeptice - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
irbesartan liconsa 150 mg
laboratorios liconsa, s.a. - irbesartanum - compr. - 150mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
juluca
viiv healthcare b.v. - dolutegravir de sodiu, clorhidrat de rilpivirină - infecții cu hiv - antivirale pentru uz sistemic - juluca este indicat pentru tratamentul infecției cu virusul imunodeficienței umane de tip 1 (hiv-1) infecții la adulți care sunt virusologic-a suprimat (arn hiv-1.
vocabria
viiv healthcare b.v. - cabotegavir sodium, cabotegravir - infecții cu hiv - antivirale pentru uz sistemic - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.
rekambys
janssen-cilag international nv - rilpivirine - infecții cu hiv - antivirale pentru uz sistemic - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.
rukobia
viiv healthcare b.v. - fostemsavir trometamol - infecții cu hiv - antivirale pentru uz sistemic - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.